NESR signs unconventional frac contract at Saudi-US Investment Forum 

Simply Wall St 3 min read In late November 2025, Zoetis Inc. announced that the European Commission granted marketing authorization for Lenivia® (izenive™), a new monoclonal antibody therapy providing up to three months of osteoarthritis pain relief in dogs after a single injection. This marks a significant expansion of Zoetis’s companion animal pain management portfolio,...

Bond Investors Find Safety in Emerging Markets - Bloomberg Dollar Depreciation Will Resume in 2026: 3-Minutes MLIV Global bond investors are beginning to view select emerging markets as safer than many far richer nations, a momentous shift that’s setting the stage for the next phase of outperformance in the asset class. The trend is most...